Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Progesterone Injection USP, 50 mg/mL, packaged in 10 mL multiple-dose vial, American Pharmaceutical Partners, ANDA 75-906 Prometrium (progesterone USP) Capsules, 100 mg Schering-Plough Research Institute NDA 19-781 5/14/98 5/15/98 5/15/98 1/6/99 Prometrium (progesterone, USP) Capsules, 100 mg, Schering NDA 20-843 12/16/98 12/17/98 12/17/98 Prometrium Indication: For use in the prevention of endometrial hyperplasia in nonhysterectomized post-menopausal women who are receiving conjugated estrogens tablets. Prochieve (progesterone gel), Columbia Prometrium (progesterone USP) Capsules, Solvay Pharmaceuticals | PROMETRIUM (progesterone) Capsules, Unimed Pharma, Labeling Revision | PROMETRIUM (progesterone) Capsules, Unimed Pharma, Labeling Revision | Progesterone Injection, Watson Labs, Labeling Revision | Endometrin (progesterone) Vaginal Insert, Ferring Pharma, Approval | Endometrin (progesterone) Vaginal Insert, Ferring Pharma, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com